Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

1.

Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: the PREMIUM Study.

Matsubara T, Naruse K, Arakawa T, Nakao M, Yokoi K, Oguri M, Marui N, Amano T, Ichimiya S, Ohashi T, Imai K, Sakai S, Sugiyama S, Ishii H, Murohara T.

J Cardiol. 2012 Nov;60(5):389-94. doi: 10.1016/j.jjcc.2012.07.012. Epub 2012 Aug 11.

PMID:
22884685
[PubMed - indexed for MEDLINE]
Free Article
2.

Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.

Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.

Clin Ther. 2007 Nov;29(11):2365-73.

PMID:
18158077
[PubMed - indexed for MEDLINE]
3.

A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.

Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.

Clin Ther. 2008 Jun;30(6):1089-101. doi: 10.1016/j.clinthera.2008.05.017.

PMID:
18640465
[PubMed - indexed for MEDLINE]
4.

Pitavastatin: an overview.

Saito Y.

Atheroscler Suppl. 2011 Nov;12(3):271-6. doi: 10.1016/S1567-5688(11)70886-8. Review.

PMID:
22152281
[PubMed - indexed for MEDLINE]
5.

Effects of pitavastatin on adiponectin in patients with hyperlipidemia.

Inami N, Nomura S, Shouzu A, Omoto S, Kimura Y, Takahashi N, Tanaka A, Nanba M, Shouda Y, Iwasaka T.

Pathophysiol Haemost Thromb. 2007;36(1):1-8. doi: 10.1159/000112633. Epub 2008 Mar 6.

PMID:
18332608
[PubMed - indexed for MEDLINE]
6.

Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.

Simons L, Tonkon M, Masana L, Maccubbin D, Shah A, Lee M, Gumbiner B.

Curr Med Res Opin. 2004 Sep;20(9):1437-45.

PMID:
15383192
[PubMed - indexed for MEDLINE]
7.

Pitavastatin: novel effects on lipid parameters.

Chapman MJ.

Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Review.

PMID:
22152282
[PubMed - indexed for MEDLINE]
8.

Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.

Kurogi K, Sugiyama S, Sakamoto K, Tayama S, Nakamura S, Biwa T, Matsui K, Ogawa H; COMPACT-CAD Investigators.

J Cardiol. 2013 Aug;62(2):87-94. doi: 10.1016/j.jjcc.2013.03.008. Epub 2013 May 11.

PMID:
23672789
[PubMed - indexed for MEDLINE]
Free Article
9.

Pitavastatin further decreases serum high-sensitive C-reactive protein levels in hypertensive patients with hypercholesterolemia treated with angiotensin II, type-1 receptor antagonists.

Yoshika M, Komiyama Y, Masuda M, Yokoi T, Masaki H, Ohkura H, Takahashi H.

Clin Exp Hypertens. 2010;32(6):341-6. doi: 10.3109/10641961003628460.

PMID:
21028996
[PubMed - indexed for MEDLINE]
10.

Pitavastatin: clinical effects from the LIVES Study.

Teramoto T.

Atheroscler Suppl. 2011 Nov;12(3):285-8. doi: 10.1016/S1567-5688(11)70888-1. Review.

PMID:
22152283
[PubMed - indexed for MEDLINE]
11.

Effects of pitavastatin on lipid profiles and high-sensitivity CRP in Japanese subjects with hypercholesterolemia: Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) investigatars.

Koshiyama H, Taniguchi A, Tanaka K, Kagimoto S, Fujioka Y, Hirata K, Nakamura Y, Iwakura A, Hara K, Yamamoto T, Kuroe A, Ohya M, Fujimoto S, Hamamoto Y, Honjo S, Ikeda H, Nabe K, Tsuda K, Inagaki N, Seino Y, Kume N; Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology Investigators.

J Atheroscler Thromb. 2008 Dec;15(6):345-50. Epub 2008 Dec 11.

PMID:
19075492
[PubMed - indexed for MEDLINE]
Free Article
12.

The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients.

Nomura S, Inami N, Shouzu A, Omoto S, Kimura Y, Takahashi N, Tanaka A, Urase F, Maeda Y, Ohtani H, Iwasaka T.

Platelets. 2009 Feb;20(1):16-22. doi: 10.1080/09537100802409921.

PMID:
19172517
[PubMed - indexed for MEDLINE]
13.

Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statin therapy in patients with acute coronary syndrome: the JAPAN-ACS subanalysis study.

Takashima H, Ozaki Y, Morimoto T, Kimura T, Hiro T, Miyauchi K, Nakagawa Y, Yamagishi M, Daida H, Mizuno T, Asai K, Kuroda Y, Kosaka T, Kuhara Y, Kurita A, Maeda K, Amano T, Matsuzaki M; JAPAN-ACS Investigators.

Circ J. 2012;76(12):2840-7. Epub 2012 Sep 7.

PMID:
22972364
[PubMed - indexed for MEDLINE]
Free Article
14.

Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.

da Silva PM.

Am J Cardiovasc Drugs. 2011;11(2):93-107. doi: 10.2165/11591190-000000000-00000. Review.

PMID:
21446776
[PubMed - indexed for MEDLINE]
15.

A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.

Park S, Kang HJ, Rim SJ, Ha JW, Oh BH, Chung N, Cho SY.

Clin Ther. 2005 Jul;27(7):1074-82.

PMID:
16154486
[PubMed - indexed for MEDLINE]
16.

Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study).

Yokote K, Bujo H, Hanaoka H, Shinomiya M, Mikami K, Miyashita Y, Nishikawa T, Kodama T, Tada N, Saito Y.

Atherosclerosis. 2008 Dec;201(2):345-52. doi: 10.1016/j.atherosclerosis.2008.02.008. Epub 2008 Feb 16.

PMID:
18472103
[PubMed - indexed for MEDLINE]
17.

Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic patients.

Nomura S, Shouzu A, Omoto S, Inami N, Shimazu T, Satoh D, Kajiura T, Yamada K, Urase F, Maeda Y, Iwasaka T.

Blood Coagul Fibrinolysis. 2009 Sep;20(6):440-7. doi: 10.1097/MBC.0b013e32832e0618.

PMID:
19525846
[PubMed - indexed for MEDLINE]
18.

Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia.

Teramoto T, Shimano H, Yokote K, Urashima M.

J Atheroscler Thromb. 2009 Oct;16(5):654-61.

PMID:
19907105
[PubMed - indexed for MEDLINE]
Free Article
19.

Combination of C-reactive protein and high molecular weight (HMW)-adiponectin reflects further metabolic abnormalities compared with each of them alone in Japanese type 2 diabetic subjects.

Saisho Y, Hirose H, Yamamoto Y, Nakatani H, Itoh H.

Endocr J. 2008 May;55(2):331-8. Epub 2008 Mar 25.

PMID:
18362454
[PubMed - indexed for MEDLINE]
Free Article
20.

Pitavastatin calcium: clinical review of a new antihyperlipidemic medication.

Yee LL, Wright EA.

Clin Ther. 2011 Aug;33(8):1023-42. doi: 10.1016/j.clinthera.2011.07.011. Epub 2011 Aug 4. Review.

PMID:
21816477
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk